Explore emerging technologies in thyroid, parathyroid and adrenal surgery at #ISITES27.
📍 Sheffield City Hall, UK
📅 17–19 March 2027
Abstracts from trainees and early-career colleagues are especially welcome.
Register or submit your abstract at https://t.co/qwW75pyNxD
Meet NASIT at ATA 2026 in Philadelphia!
📍 Table TT3, exhibit hall entrance
Exhibit hours:
Thu Nov 5: 10:15am–7:15pm
Fri Nov 6: 10am–4:30pm
Sat Nov 7: 8:30am–noon
Stop by, connect, and learn about NASIT 2027 in Orlando!
#NASIT#Thyroid
Endocrine Practice Highlight: North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Benign Non-functional Thyroid Nodules
North American Society for Interventional Thyroidology’s statement clarifies candidate selection, counseling, and expected outcomes for clinicians, while summarizing procedural techniques and highlighting key areas of ongoing research and innovation. Read more:https://t.co/Vi804Q7cRP
Your research deserves to be shared! The NASIT 2027 call for abstracts is open. Submit your interesting clinical cases & scientific research in minimally invasive thyroid therapies.
📅 Deadline: November 15, 26
🔗 Submit: https://t.co/dvBdxtLNo4
#NASIT2027#ThyroidAblation
Where does thyroid artery embolization (TAE) fit in modern care? NASIT’s new statement in Endocrine Practice reviews the current evidence.
A practical update for clinicians involved in minimally invasive
treatments
🔗 https://t.co/Zcm2ceN7f0
#ThyroidAblation#Embolization
NASIT is proud to share its statement on Directed Ablative Therapy for benign non-functional thyroid nodules, published in Endocrine Practice.
A timely resource on patient selection, counseling, technique, outcomes, safety, and follow-up.
https://t.co/mY30gkXKsU
Excellent @NASITablate meeting! Had the pleasure to participate and connect with friends and colleagues in the field of minimally invasive thyroid techniques @WashUDeptMed@WashUMedEndo
As the 2026 @NASITablate annual meeting comes to an end, we are grateful for the vibrant community advancing minimally invasive treatments for thyroid disease.
Thank you to all who joined us in Portland. Your participation made this meeting truly special.
Safe travels home.
Congratulations to the President of @NASITablate, Dr Huber, and the entire team for an exceptional meeting. Organizing a conference of this caliber takes vision, commitment, and countless hours of work. Thank you for your leadership and for advancing interventional Thyroidology
Wrapping up #NASITablate with the Video Session.
A unique opportunity to learn from real procedures, technical pearls, and challenging cases in interventional thyroidology.
An outstanding close to a remarkable meeting.
Congratulations to Dr. Baek on this outstanding recognition.
His pioneering work in minimally invasive thyroid treatments has helped shape the field and continues to inspire colleagues worldwide.
Proud to celebrate this moment at #NASITablate.
A valuable session at @NASITablate focusing on challenging cases and complications.
Real-world experiences, difficult decisions, and lessons to improve safety and outcomes.
Learning from complexity is how the field advances.
#NASIT#Thyroid#InterventionalThyroidology
Day 2 at @NASITablate begins with an exciting session on the future of ablation.
Discussion focuses on the potential of non-thermal ablation using nsPFA — a technology that may redefine tissue-selective treatment in interventional thyroidology.
#NASIT#Thyroid#Ablation#PFA
Interested in thyroid disease, advanced US and minimally invasive treatments?
Join the conversation with experts exploring the future of image-guided thyroid therapies including RFA / MWA ablation
Follow us @NASITablate and stay connected with the global community.
Innovation in ablation continues.
At @NASITablate, Dr. Stefano Spiezia is presenting nsPFA (nanosecond Pulsed Field Ablation) — an emerging technology with potential applications in thyroid disease.
The field keeps evolving.
#nsPFA#Ablation#InterventionalThyroidology#NASIT
Insightful lecture at @NASITablate by Dr. Ana Vogg on Parathyroid RFA, an emerging minimally invasive treatment for hyperparathyroidism.
Image-guided endocrine therapies continue to expand the therapeutic landscape.
#Parathyroid#RFA#NASIT#InterventionalThyroidology